MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Prostate
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)
Organization & Developments: Fusion Pharmaceuticals
Parents
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)
Children
*Fusion connects alpha particle emitting isotopes to various targeting molecules in order to selectively deliver the alpha emitting payloads to tumors.
*Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation RCs.
*Next-Generation Radiopharmaceuticals for precision medicine
2023: Recent M&A Bodes Well For Targeted Cancer Therapy Player Fusion Pharmaceuticals, Analyst Say AstraZeneca Is Favorably Positioned_RayzeBio, POINT Biopharma Global
2024: Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer
2024: Fusion Pharmaceuticals' Partnerships Strengthen Long-Term Outlook
Jumps
Finance & Acquisitions: Fusion Pharmaceuticals
Key People: Fusion Pharmaceuticals